Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up

Saturday, September 29, 2018 - 12:10 in Mathematics & Economics

With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net